Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Fuji
Covington
AstraZeneca
Queensland Health
Mallinckrodt
Merck
Citi
QuintilesIMS

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087958

« Back to Dashboard

NDA 087958 describes HEPARIN LOCK FLUSH, which is a drug marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, and Solopak, and is included in seventeen NDAs. Additional details are available on the HEPARIN LOCK FLUSH profile page.

The generic ingredient in HEPARIN LOCK FLUSH is heparin sodium. There are seventy-seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for 087958
Tradename:HEPARIN LOCK FLUSH
Applicant:Smith And Nephew
Ingredient:heparin sodium
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10 UNITS/ML
Approval Date:Apr 20, 1983TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
QuintilesIMS
Farmers Insurance
Boehringer Ingelheim
Mallinckrodt
Julphar
Deloitte
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.